Epilepsy Clinical Trial
Official title:
Cooling of the Head and Neck to Reduce Seizure Frequency: A Pilot Study
Verified date | June 13, 2008 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Doctors use cooling of the brain to help stop seizures. This procedure is usually
accomplished through surgery. Cooling of the face and scalp may also cool the brain, avoiding
the need for surgery.
The purpose of this study is to assess a head-neck cooling device that the patient can wear.
Researchers will determine whether the device can change the frequency of seizures in people
with epilepsy.
Study participants must be 21 years of age or older and must experience seizures that occur
once a week on a regular basis. Participants will be asked to keep a detailed seizure diary
for a 12-week period before the date of the first cooling session. For each of the four
cooling sessions, participants will be admitted to the hospital overnight. They will undergo
a physical and neurological exam and an EEG (electroencephalogram). They will also swallow a
temperature-sensor pill. Participants will have one 60-minute cooling session once a week for
4 weeks. Investigators will paste temperature-sensing electrodes on the scalp, forearm,
abdomen, and leg. Participants will then be fitted with the cooling unit and the session will
begin.
Status | Completed |
Enrollment | 5 |
Est. completion date | May 22, 2007 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | All |
Age group | 21 Years to 65 Years |
Eligibility |
- INCLUSION CRITERIA: A minimum of one documented seizure of any type per a 1-week period. 21 years or older, and able to cooperate with the cooling procedures. On a stable antiepileptic drug (AED) regimen, as determined by history and by AED plasma levels as measured in the CC OPD. The ability to maintain a daily seizure calendar, either independently or with help from a family member. No history of intestinal problems or history of intestinal surgery. Must be able to swallow medication in capsule form. EXCLUSION CRITERIA: Female patients who are pregnant. Those patients under 21 years of age. Those patients who may have difficulty swallowing a large capsule, or describing their feelings and experiences related to the cooling sessions. Those patients with a history of intestinal problems or intestinal surgery Those patients with progressive neurological disorders Those sensitive to coldness History of severe 'ice-cream' headache |
Country | Name | City | State |
---|---|---|---|
United States | National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institute of Neurological Disorders and Stroke (NINDS) |
United States,
Cabanac M. Selective brain cooling in humans: "fancy" or fact? FASEB J. 1993 Sep;7(12):1143-6; discussion 1146-7. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Identify optimal cooling parameters,namely duration and frequency of cooling for reducing seizure frequency. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04595513 -
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
|
Phase 1/Phase 2 | |
Completed |
NCT02909387 -
Adapting Project UPLIFT for Blacks in Georgia
|
N/A | |
Completed |
NCT05552924 -
Self Acupressure on Fatigue and Sleep Quality in Epilepsy Patients
|
N/A | |
Terminated |
NCT01668654 -
Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS
|
Phase 3 | |
Not yet recruiting |
NCT05068323 -
Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients
|
N/A | |
Completed |
NCT03994718 -
Creative Arts II Study
|
N/A | |
Recruiting |
NCT04076449 -
Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
|
||
Completed |
NCT00782249 -
Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy
|
N/A | |
Completed |
NCT03683381 -
App-based Intervention for Treating Insomnia Among Patients With Epilepsy
|
N/A | |
Recruiting |
NCT05101161 -
Neurofeedback Using Implanted Deep Brain Stimulation Electrodes
|
N/A | |
Active, not recruiting |
NCT06034353 -
Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients
|
N/A | |
Recruiting |
NCT05769933 -
Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
|
||
Not yet recruiting |
NCT06408428 -
Glioma Intraoperative MicroElectroCorticoGraphy
|
N/A | |
Not yet recruiting |
NCT05559060 -
Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction)
|
||
Completed |
NCT02952456 -
Phenomenological Approach of Epilepsy in Patients With Epilepsy
|
||
Completed |
NCT02977208 -
Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use
|
Phase 4 | |
Completed |
NCT02646631 -
Behavioral and Educational Tools to Improve Epilepsy Care
|
N/A | |
Recruiting |
NCT02539134 -
TAK-935 Multiple Rising Dose Study in Healthy Participants
|
Phase 1 | |
Completed |
NCT02491073 -
Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)
|
N/A | |
Terminated |
NCT02757547 -
Transcranial Magnetic Stimulation for Epilepsy
|
N/A |